Literature DB >> 215555

Effect of erythromycin and amoxycillin on Bordetella pertussis in the nasopharynx.

B Trollfors.   

Abstract

The effectiveness of oral erythromycin and amoxycillin in eradicating Bordetella pertussis from the nasopharynx was compared. Erythromycin in a dosage of 40--50 mg/kg/day was significantly more effective than amoxycillin in a dosage of 25--30 mg/kg/day. The organism did not disappear in three cases receiving a lower dosage of erythromycin. As antibiotic treatment does not affect the clinical course of fully-developed whooping cough, erythromycin is indicated primarily when particularly susceptible individuals are threatened by exposure. In such cases erythromycin should be given as soon as whooping cough is suspected.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215555     DOI: 10.1007/bf01642314

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Laboratory evaluation of amoxicillin.

Authors:  G N Rolinson
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

2.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

3.  Letter: The role of antimicrobial agents in the treatment of pertussis.

Authors:  J W Bass
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

4.  Whooping cough.

Authors:  W M Jamieson
Journal:  Br Med J       Date:  1973-01-27

5.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

6.  Antimicrobial treatment of pertussis.

Authors:  J W Bass; E L Klenk; J B Kotheimer; C C Linnemann; M H Smith
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

7.  Susceptibility of Bordetella pertussis to nine antimicrobial agents.

Authors:  J W Bass; F W Crast; J B Kotheimer; I A Mitchell
Journal:  Am J Dis Child       Date:  1969-03

8.  Amoxicillin in the treatment of infections of the lower respiratory tract.

Authors:  J R May; A Ingold
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

9.  Antibiotic treatment of pertussis.

Authors:  J D Nelson
Journal:  Pediatrics       Date:  1969-10       Impact factor: 7.124

10.  The whooping cough syndrome: A continuing pediatric problem.

Authors:  J Islur; C S Anglin; P J Middleton
Journal:  Clin Pediatr (Phila)       Date:  1975-02       Impact factor: 1.168

View more
  6 in total

Review 1.  Treatment and prevention of pertussis by antimicrobial agents (Part II).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

2.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

3.  Influence of culture medium and inoculum size on susceptibility of Bordetella pertussis to antibacterial agents in vitro.

Authors:  G Zackrisson; J E Brorson; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

Review 4.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 5.  Management of acute bronchitis in healthy adults.

Authors:  Eva Aagaard; Ralph Gonzales
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

6.  High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.

Authors:  Lijun Li; Jikui Deng; Xiang Ma; Kai Zhou; Qinghong Meng; Lin Yuan; Wei Shi; Qing Wang; Yue Li; Kaihu Yao
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.